Clinical trial

Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fraction

NCT05672134

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-04-26

PhasePHASE2

Study timeline

Study start (actual)2023-04-26Date precision: day

Registry last updated2025-04-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Preserved Ejection Fractionunresolved

Interventions

Iohexol measurementDIAGNOSTIC_TEST

Geranylgeranylacetone (GGA)DRUG

EchocardiographyDIAGNOSTIC_TEST

6-minute walking distance testDIAGNOSTIC_TEST

EndoPATDIAGNOSTIC_TEST

Para-amino Hippuric Acid testDIAGNOSTIC_TEST

ElectrocardiogramDIAGNOSTIC_TEST

Sponsors & collaborators

Amsterdam UMC, location VUmclead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05672134 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.